vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and TRUPANION, INC. (TRUP). Click either name above to swap in a different company.
TRUPANION, INC. is the larger business by last-quarter revenue ($376.9M vs $284.0M, roughly 1.3× ACADIA PHARMACEUTICALS INC). On growth, TRUPANION, INC. posted the faster year-over-year revenue change (11.7% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 11.0%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
TRUPANION, INC.TRUPEarnings & Financial Report
Trupanion, Inc. is a pet insurance provider headquartered in Seattle, Washington. Established in 1998, Trupanion operates across the United States, Canada, Australia, and Puerto Rico. The company offers coverage for pets and is self-underwritten by the American Pet Insurance Company (APIC).
ACAD vs TRUP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $376.9M |
| Net Profit | $273.6M | — |
| Gross Margin | 90.8% | 17.3% |
| Operating Margin | 6.1% | 1.9% |
| Net Margin | 96.3% | — |
| Revenue YoY | 9.4% | 11.7% |
| Net Profit YoY | 90.3% | — |
| EPS (diluted) | $1.61 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $376.9M | ||
| Q3 25 | $278.6M | $366.9M | ||
| Q2 25 | $264.6M | $353.6M | ||
| Q1 25 | $244.3M | $342.0M | ||
| Q4 24 | $259.6M | $337.3M | ||
| Q3 24 | $250.4M | $327.5M | ||
| Q2 24 | $242.0M | $314.8M | ||
| Q1 24 | $205.8M | $306.1M |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | — | ||
| Q2 25 | $26.7M | — | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $16.6M | — |
| Q4 25 | 90.8% | 17.3% | ||
| Q3 25 | 92.2% | 16.4% | ||
| Q2 25 | 92.2% | 15.5% | ||
| Q1 25 | 91.7% | 14.9% | ||
| Q4 24 | 91.6% | 15.7% | ||
| Q3 24 | 92.5% | 15.1% | ||
| Q2 24 | 92.5% | 12.8% | ||
| Q1 24 | 88.8% | 11.8% |
| Q4 25 | 6.1% | 1.9% | ||
| Q3 25 | 12.8% | 1.6% | ||
| Q2 25 | 12.2% | 0.7% | ||
| Q1 25 | 7.9% | -0.4% | ||
| Q4 24 | 59.1% | 0.1% | ||
| Q3 24 | 12.6% | 0.5% | ||
| Q2 24 | 12.6% | -1.7% | ||
| Q1 24 | 7.4% | -2.0% |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | — | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 8.0% | — |
| Q4 25 | $1.61 | $0.13 | ||
| Q3 25 | $0.42 | $0.13 | ||
| Q2 25 | $0.16 | $0.22 | ||
| Q1 25 | $0.11 | $-0.03 | ||
| Q4 24 | $0.86 | $0.04 | ||
| Q3 24 | $0.20 | $0.03 | ||
| Q2 24 | $0.20 | $-0.14 | ||
| Q1 24 | $0.10 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $370.7M |
| Total DebtLower is stronger | — | $101.8M |
| Stockholders' EquityBook value | $1.2B | $383.9M |
| Total Assets | $1.6B | $915.0M |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $370.7M | ||
| Q3 25 | $258.0M | $348.5M | ||
| Q2 25 | $253.6M | $319.6M | ||
| Q1 25 | $217.7M | $321.8M | ||
| Q4 24 | $319.6M | $307.4M | ||
| Q3 24 | $155.1M | $293.1M | ||
| Q2 24 | $177.1M | $277.2M | ||
| Q1 24 | $204.7M | $275.2M |
| Q4 25 | — | $101.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $127.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $383.9M | ||
| Q3 25 | $917.3M | $368.6M | ||
| Q2 25 | $822.4M | $355.5M | ||
| Q1 25 | $765.2M | $333.7M | ||
| Q4 24 | $732.8M | $323.3M | ||
| Q3 24 | $577.2M | $320.2M | ||
| Q2 24 | $516.7M | $305.8M | ||
| Q1 24 | $464.0M | $303.4M |
| Q4 25 | $1.6B | $915.0M | ||
| Q3 25 | $1.3B | $880.2M | ||
| Q2 25 | $1.2B | $847.8M | ||
| Q1 25 | $1.1B | $837.2M | ||
| Q4 24 | $1.2B | $806.9M | ||
| Q3 24 | $976.9M | $816.1M | ||
| Q2 24 | $914.1M | $795.9M | ||
| Q1 24 | $855.1M | $789.5M |
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.39× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $29.3M |
| Free Cash FlowOCF − Capex | — | $25.3M |
| FCF MarginFCF / Revenue | — | 6.7% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $75.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $29.3M | ||
| Q3 25 | $74.3M | $29.2M | ||
| Q2 25 | $64.0M | $15.0M | ||
| Q1 25 | $20.3M | $16.0M | ||
| Q4 24 | $40.4M | $23.7M | ||
| Q3 24 | $63.2M | $15.3M | ||
| Q2 24 | $25.0M | $6.9M | ||
| Q1 24 | $29.1M | $2.4M |
| Q4 25 | — | $25.3M | ||
| Q3 25 | $73.9M | $23.9M | ||
| Q2 25 | — | $12.0M | ||
| Q1 25 | — | $14.0M | ||
| Q4 24 | — | $21.8M | ||
| Q3 24 | $63.2M | $13.4M | ||
| Q2 24 | — | $4.0M | ||
| Q1 24 | — | $-631.0K |
| Q4 25 | — | 6.7% | ||
| Q3 25 | 26.5% | 6.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 4.1% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | 25.2% | 4.1% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | -0.2% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | 0.1% | 1.4% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
TRUP
| Subscriptionbusiness | $261.4M | 69% |
| Other | $115.4M | 31% |
